UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
20.01
-0.71 (-3.43%)
At close: Aug 6, 2025, 4:00 PM
20.20
+0.19 (0.95%)
After-hours: Aug 6, 2025, 7:14 PM EDT
Smartsheet Stock Forecast
Stock Price Forecast
The 8 analysts that cover Smartsheet stock have a consensus rating of "Strong Buy" and an average price target of $29, which forecasts a 44.93% increase in the stock price over the next year. The lowest target is $3.00 and the highest is $50.
Price Target: $29.00 (+44.93%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Smartsheet stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Hold | 0 | 1 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +24.94% | Aug 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +149.88% | Jul 8, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +24.94% | Jul 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $50 | Hold → Strong Buy | Upgrades | $50 | +149.88% | Jun 16, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $10 → $31 | Buy | Maintains | $10 → $31 | +54.92% | Jun 13, 2025 |
Financial Forecast
Revenue This Year
126.38M
from 90.40M
Increased by 39.80%
Revenue Next Year
264.06M
from 126.38M
Increased by 108.94%
EPS This Year
-2.97
from -2.96
EPS Next Year
-1.32
from -2.97
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 143.3M | 411.1M | 741.7M |
| Avg | 126.4M | 264.1M | 404.8M |
| Low | 109.9M | 219.9M | 298.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 58.6% | 225.2% | 180.9% |
| Avg | 39.8% | 108.9% | 53.3% |
| Low | 21.6% | 74.0% | 13.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.35 | 2.14 | 4.24 |
| Avg | -2.97 | -1.32 | 0.70 |
| Low | -3.40 | -3.03 | -1.39 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.